
    
      The primary objective of this study is to demonstrate the safety and to report clinical
      performance of the CardioMEMS™ HF System in real world setting.

      Prospective, non-randomized, open-label, multi-center, post-market study designed to
      characterize the use of the CardioMEMS™ HF System in a real-world setting in the US; N=1200.
      It is the condition of approval study.
    
  